Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: It is controversial whether iRECIST has a significant impact over RECIST 1.1 in evaluating the efficacy of immune checkpoint inhibitor treatment. We aimed to evaluate the impact of iRECIST on assessing treatment efficacy of immune checkpoint inhibitors over RECIST 1.1 through a syste...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Park, Hyo Jung, Kim, Gun Ha, Kim, Kyung Won, Lee, Choong Wook, Yoon, Shinkyo, Chae, Young Kwang, Tirumani, Sree Harsha, Ramaiya, Nikhil H.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Systematic Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795764/
https://ncbi.nlm.nih.gov/pubmed/33561078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados